Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Virology, pathogenesis, and epidemiology of human herpesvirus 6 infection

Cécile Tremblay, MD
Section Editor
Martin S Hirsch, MD
Deputy Editor
Anna R Thorner, MD


Human herpesvirus 6 (HHV-6) was first isolated and characterized from patients with lymphoproliferative disorders [1] and was originally named human B-lymphotropic virus. Its name was changed to human herpesvirus 6 as its tropism was further characterized [2].

The virology, pathogenesis, and epidemiology of HHV-6 infection will be discussed here. The clinical manifestations, diagnosis, and treatment in adults and children are presented separately; HHV-6 infection in hematopoietic cell transplant recipients is also discussed elsewhere. (See "Clinical manifestations, diagnosis, and treatment of human herpesvirus 6 infection in adults" and "Human herpesvirus 6 infection in children: Clinical manifestations, diagnosis, and treatment" and "Human herpesvirus 6 infection in hematopoietic cell transplant recipients".)


Human herpesvirus 6 (HHV-6) is a member of the Herpesviridae family. Its genetic and biologic similarities to human cytomegalovirus (CMV) have prompted its classification in the beta herpesvirus subfamily (genus Roseolovirus, along with human herpesvirus 7 [HHV-7]) [3]. There are two HHV-6 variants, HHV-6A and HHV-6B. Based on their distinctive biological properties and genome sequences, HHV-6A and HHV-6B are classified as two distinct herpesvirus species [4]. HHV-6A and HHV-6B also differ in epidemiology, growth properties, antigenic properties, and restriction endonuclease profiles [5-8]. The nucleotide sequence identity between the two variants ranges from 75 to 95 percent depending upon which gene is compared.


As with other herpes viruses, mature human herpesvirus 6 (HHV-6) virions are double-stranded DNA viruses, approximately 200 nm in diameter and are composed of four main structural elements: an electron-dense core, a capsid with icosahedral symmetry, a tegument, and an outer envelope.

Cell tropism — HHV-6 replicates most efficiently in vitro in activated primary T cells as well as in continuous T cell lines. However, the virus can also replicate with varying efficiency in a wide array of host cell types including monocytes/macrophages, natural killer cells, astrocytes, megakaryocytes, and glial cell lineages [2,9-12]. HHV-6 can also be recovered in vivo from a broad range of tissues such as lymph nodes, peripheral blood mononuclear cells (PBMCs), renal tubular cells, salivary glands, and the central nervous system [13-19]. HHV-6 has also been identified in astrocytes from gliomas, suggesting a potential role in tumorigenesis [20,21].

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Nov 14, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Salahuddin SZ, Ablashi DV, Markham PD, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986; 234:596.
  2. Ablashi DV, Salahuddin SZ, Josephs SF, et al. HBLV (or HHV-6) in human cell lines. Nature 1987; 329:207.
  3. Yamanishi K, Mori Y, Pellett PE. Human herpesvirus 6 and 7. In: Fields Virology, 6th edition, Knipe DM, Howley P. (Eds), Wolters Kluwer Health, Philadelphia 2013. Vol 2, p.2058.
  4. International Committee on Taxonomy of Viruses. ICTV Master Species List 2011. http://talk.ictvonline.org/files/ictv_documents/m/msl/4090.aspx (Accessed on June 27, 2012).
  5. Ablashi DV, Balachandran N, Josephs SF, et al. Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. Virology 1991; 184:545.
  6. Aubin JT, Agut H, Collandre H, et al. Antigenic and genetic differentiation of the two putative types of human herpes virus 6. J Virol Methods 1993; 41:223.
  7. Dewhurst S, Chandran B, McIntyre K, et al. Phenotypic and genetic polymorphisms among human herpesvirus-6 isolates from North American infants. Virology 1992; 190:490.
  8. Achour A, Malet I, Le Gal F, et al. Variability of gB and gH genes of human herpesvirus-6 among clinical specimens. J Med Virol 2008; 80:1211.
  9. Cermelli C, Concari M, Carubbi F, et al. Growth of human herpesvirus 6 in HEPG2 cells. Virus Res 1996; 45:75.
  10. Chen M, Popescu N, Woodworth C, et al. Human herpesvirus 6 infects cervical epithelial cells and transactivates human papillomavirus gene expression. J Virol 1994; 68:1173.
  11. He J, McCarthy M, Zhou Y, et al. Infection of primary human fetal astrocytes by human herpesvirus 6. J Virol 1996; 70:1296.
  12. Luka J, Okano M, Thiele G. Isolation of human herpesvirus-6 from clinical specimens using human fibroblast cultures. J Clin Lab Anal 1990; 4:483.
  13. Levine PH, Jahan N, Murari P, et al. Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). J Infect Dis 1992; 166:291.
  14. Cone RW, Huang ML, Ashley R, Corey L. Human herpesvirus 6 DNA in peripheral blood cells and saliva from immunocompetent individuals. J Clin Microbiol 1993; 31:1262.
  15. Kondo K, Kondo T, Okuno T, et al. Latent human herpesvirus 6 infection of human monocytes/macrophages. J Gen Virol 1991; 72 ( Pt 6):1401.
  16. Okuno T, Higashi K, Shiraki K, et al. Human herpesvirus 6 infection in renal transplantation. Transplantation 1990; 49:519.
  17. Krueger GR, Wassermann K, De Clerck LS, et al. Latent herpesvirus-6 in salivary and bronchial glands. Lancet 1990; 336:1255.
  18. Challoner PB, Smith KT, Parker JD, et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A 1995; 92:7440.
  19. Luppi M, Barozzi P, Maiorana A, et al. Human herpesvirus 6 infection in normal human brain tissue. J Infect Dis 1994; 169:943.
  20. Crawford JR, Santi MR, Thorarinsdottir HK, et al. Detection of human herpesvirus-6 variants in pediatric brain tumors: association of viral antigen in low grade gliomas. J Clin Virol 2009; 46:37.
  21. Crawford JR, Santi MR, Cornelison R, et al. Detection of human herpesvirus-6 in adult central nervous system tumors: predominance of early and late viral antigens in glial tumors. J Neurooncol 2009; 95:49.
  22. Kondo K, Kondo T, Shimada K, et al. Strong interaction between human herpesvirus 6 and peripheral blood monocytes/macrophages during acute infection. J Med Virol 2002; 67:364.
  23. Andre-Garnier E, Milpied N, Boutolleau D, et al. Reactivation of human herpesvirus 6 during ex vivo expansion of circulating CD34+ haematopoietic stem cells. J Gen Virol 2004; 85:3333.
  24. Santoro F, Kennedy PE, Locatelli G, et al. CD46 is a cellular receptor for human herpesvirus 6. Cell 1999; 99:817.
  25. Mori Y, Yang X, Akkapaiboon P, et al. Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46. J Virol 2003; 77:4992.
  26. Smith A, Santoro F, Di Lullo G, et al. Selective suppression of IL-12 production by human herpesvirus 6. Blood 2003; 102:2877.
  27. Karp CL, Wysocka M, Wahl LM, et al. Mechanism of suppression of cell-mediated immunity by measles virus. Science 1996; 273:228.
  28. Tang H, Serada S, Kawabata A, et al. CD134 is a cellular receptor specific for human herpesvirus-6B entry. Proc Natl Acad Sci U S A 2013; 110:9096.
  29. Tang H, Mori Y. Determinants of Human CD134 Essential for Entry of Human Herpesvirus 6B. J Virol 2015; 89:10125.
  30. Nacheva EP, Ward KN, Brazma D, et al. Human herpesvirus 6 integrates within telomeric regions as evidenced by five different chromosomal sites. J Med Virol 2008; 80:1952.
  31. Mori Y, Koike M, Moriishi E, et al. Human herpesvirus-6 induces MVB formation, and virus egress occurs by an exosomal release pathway. Traffic 2008; 9:1728.
  32. Lusso P, Gallo RC, DeRocco SE, Markham PD. CD4 is not the membrane receptor for HHV-6. Lancet 1989; 1:730.
  33. Di Luca D, Katsafanas G, Schirmer EC, et al. The replication of viral and cellular DNA in human herpesvirus 6-infected cells. Virology 1990; 175:199.
  34. Lusso P, Malnati M, De Maria A, et al. Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3. J Immunol 1991; 147:685.
  35. Singh N. Interactions between viruses in transplant recipients. Clin Infect Dis 2005; 40:430.
  36. Nagasaka M, Morioka I, Kawabata A, et al. Comprehensive analysis of serum cytokines/chemokines in febrile children with primary human herpes virus-6B infection. J Infect Chemother 2016; 22:593.
  37. Gupta S, Agrawal S, Gollapudi S. Differential effect of human herpesvirus 6A on cell division and apoptosis among naive and central and effector memory CD4+ and CD8+ T-cell subsets. J Virol 2009; 83:5442.
  38. Takemoto M, Imasawa T, Yamanishi K, Mori Y. Role of dendritic cells infected with human herpesvirus 6 in virus transmission to CD4(+) T cells. Virology 2009; 385:294.
  39. Tai AK, Luka J, Ablashi D, Huber BT. HHV-6A infection induces expression of HERV-K18-encoded superantigen. J Clin Virol 2009; 46:47.
  40. Flamand L, Stefanescu I, Menezes J. Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. J Clin Invest 1996; 97:1373.
  41. Hall CB, Long CE, Schnabel KC, et al. Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med 1994; 331:432.
  42. Gompels UA, Nicholas J, Lawrence G, et al. The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology 1995; 209:29.
  43. Lindquester GJ, Inoue N, Allen RD, et al. Restriction endonuclease mapping and molecular cloning of the human herpesvirus 6 variant B strain Z29 genome. Arch Virol 1996; 141:367.
  44. Wang B, Nishimura M, Tang H, et al. Crystal Structure of Human Herpesvirus 6B Tegument Protein U14. PLoS Pathog 2016; 12:e1005594.
  45. Wallaschek N, Gravel A, Flamand L, Kaufer BB. The putative U94 integrase is dispensable for human herpesvirus 6 (HHV-6) chromosomal integration. J Gen Virol 2016; 97:1899.
  46. Trempe F, Gravel A, Dubuc I, et al. Characterization of human herpesvirus 6A/B U94 as ATPase, helicase, exonuclease and DNA-binding proteins. Nucleic Acids Res 2015; 43:6084.
  47. Mori J, Tang H, Kawabata A, et al. Human Herpesvirus 6A U14 Is Important for Virus Maturation. J Virol 2015; 90:1677.
  48. Mahmoud NF, Kawabata A, Tang H, et al. Human herpesvirus 6 U11 protein is critical for virus infection. Virology 2016; 489:151.
  49. Mahmoud NF, Jasirwan C, Kanemoto S, et al. Cytoplasmic tail domain of glycoprotein B is essential for HHV-6 infection. Virology 2016; 490:1.
  50. Pfeiffer B, Berneman ZN, Neipel F, et al. Identification and mapping of the gene encoding the glycoprotein complex gp82-gp105 of human herpesvirus 6 and mapping of the neutralizing epitope recognized by monoclonal antibodies. J Virol 1993; 67:4611.
  51. Horvat RT, Wood C, Balachandran N. Transactivation of human immunodeficiency virus promoter by human herpesvirus 6. J Virol 1989; 63:970.
  52. Lusso P, Ensoli B, Markham PD, et al. Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6. Nature 1989; 337:370.
  53. Lusso P, Malnati MS, Garzino-Demo A, et al. Infection of natural killer cells by human herpesvirus 6. Nature 1993; 362:458.
  54. Ranger S, Patillaud S, Denis F, et al. Seroepidemiology of human herpesvirus-6 in pregnant women from different parts of the world. J Med Virol 1991; 34:194.
  55. Levy JA, Ferro F, Greenspan D, Lennette ET. Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population. Lancet 1990; 335:1047.
  56. Okuno T, Takahashi K, Balachandra K, et al. Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol 1989; 27:651.
  57. Brown NA, Sumaya CV, Liu CR, et al. Fall in human herpesvirus 6 seropositivity with age. Lancet 1988; 2:396.
  58. Zerr DM, Meier AS, Selke SS, et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med 2005; 352:768.
  59. Dewhurst S, McIntyre K, Schnabel K, Hall CB. Human herpesvirus 6 (HHV-6) variant B accounts for the majority of symptomatic primary HHV-6 infections in a population of U.S. infants. J Clin Microbiol 1993; 31:416.
  60. Kasolo FC, Mpabalwani E, Gompels UA. Infection with AIDS-related herpesviruses in human immunodeficiency virus-negative infants and endemic childhood Kaposi's sarcoma in Africa. J Gen Virol 1997; 78 ( Pt 4):847.
  61. Knox KK, Carrigan DR. Active HHV-6 infection in the lymph nodes of HIV-infected patients: in vitro evidence that HHV-6 can break HIV latency. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 11:370.
  62. Hall CB, Caserta MT, Schnabel KC, et al. Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A. Clin Infect Dis 1998; 26:132.
  63. De Bolle L, Van Loon J, De Clercq E, Naesens L. Quantitative analysis of human herpesvirus 6 cell tropism. J Med Virol 2005; 75:76.
  64. American Academy of Pediatrics. Human herpesvirus 6 (including roseola) and 7. In: Red Book: 2015 Report of the Committee on Infectious Diseases, 30th ed, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2015. p.449.
  65. Hall CB, Caserta MT. Exanthem subitum (Roseola infantum). Herpes 1999; 6:64.
  66. Wyatt LS, Frenkel N. Human herpesvirus 7 is a constitutive inhabitant of adult human saliva. J Virol 1992; 66:3206.
  67. Di Luca D, Mirandola P, Ravaioli T, et al. Human herpesviruses 6 and 7 in salivary glands and shedding in saliva of healthy and human immunodeficiency virus positive individuals. J Med Virol 1995; 45:462.
  68. Pereira CM, Gasparetto PF, Corrêa ME, et al. Human herpesvirus 6 in oral fluids from healthy individuals. Arch Oral Biol 2004; 49:1043.
  69. Roush KS, Domiati-Saad RK, Margraf LR, et al. Prevalence and cellular reservoir of latent human herpesvirus 6 in tonsillar lymphoid tissue. Am J Clin Pathol 2001; 116:648.
  70. Baillargeon J, Piper J, Leach CT. Epidemiology of human herpesvirus 6 (HHV-6) infection in pregnant and nonpregnant women. J Clin Virol 2000; 16:149.
  71. Dahl H, Fjaertoft G, Norsted T, et al. Reactivation of human herpesvirus 6 during pregnancy. J Infect Dis 1999; 180:2035.
  72. Hall CB, Caserta MT, Schnabel KC, et al. Congenital infections with human herpesvirus 6 (HHV6) and human herpesvirus 7 (HHV7). J Pediatr 2004; 145:472.
  73. Aubin JT, Poirel L, Agut H, et al. Intrauterine transmission of human herpesvirus 6. Lancet 1992; 340:482.
  74. Ashshi AM, Cooper RJ, Klapper PE, et al. Detection of human herpes virus 6 DNA in fetal hydrops. Lancet 2000; 355:1519.
  75. Asano Y, Yoshikawa T, Suga S, et al. Fatal fulminant hepatitis in an infant with human herpesvirus-6 infection. Lancet 1990; 335:862.